Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 3Not yet recruiting 3Recruiting 2Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Neuroblastoma 1Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × hetrombopag × Clear all
NCT07492693 2026-03-25

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

Changhai Hospital

Phase 2 Recruiting
40 enrolled
Classical hematologyGastrointestinal

Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors

NCT06818916 2025-12-03

Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma

Beijing Children's Hospital

Phase NA Recruiting
30 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡